Rhodiola Rosea: History and Traditional Use

Rhodiola rosea — the “golden root” or roseroot — is a small, tough mountain plant that has been gathered as a medicine for nearly two thousand years across the cold edges of Europe and Asia. Its written record begins with a Greek-born physician of the Roman army in the first century, runs through Carl Linnaeus and the first Swedish pharmacy lists, and survives in the folk medicine of Siberia, Scandinavia, and the high mountains of Asia. In the twentieth century the herb became the focus of a sweeping, partly secret Soviet research program. This article tells that documented story plainly, marks tradition clearly as tradition, and shows how an old folk tonic became one of the most-studied adaptogens in modern science.

Table of Contents

  1. Naming the Golden Root
  2. The Earliest Written Record: Dioscorides
  3. Linnaeus and Early European Pharmacy
  4. Siberian and Russian Folk Medicine
  5. Scandinavia and the Viking Tradition
  6. Traditional Chinese and Tibetan Medicine
  7. The Soviet Adaptogen Program
  8. From Folk Tonic to Modern Recognition
  9. Research Papers and References
  10. Connections
  11. Featured Videos

Naming the Golden Root

Rhodiola rosea is a hardy perennial of the stonecrop family (Crassulaceae), the same family as the common garden sedums and houseleeks. It grows in some of the harshest places plants can live — Arctic tundra, windswept sea cliffs, and alpine ledges across the cold Northern Hemisphere, from Scandinavia and Iceland through the Alps and the Carpathians to the Altai Mountains and Siberia. People who lived alongside it could hardly miss it, and over the centuries it gathered a long list of common names that double as a record of how it was seen and used.

The most familiar names point straight at the root. Cut open, the thick rhizome is a striking golden-yellow, which gives the plant its best-known English names — golden root, the Russian zolotoy koren (“golden root”), and the regal-sounding king’s crown. The freshly cut root also gives off a scent that many describe as rose-like, and it is this fragrance, not the plant’s yellowish flowers, that lies behind both the genus name Rhodiola (from the Greek rhodon, “rose”) and the species name rosea. Other widely used names — roseroot, Arctic root, and rosenroot — combine that rose scent with the plant’s cold northern home.

One small botanical detail shaped its history of cultivation. Rhodiola rosea is dioecious, meaning each plant is either male or female — a relatively unusual trait that, together with the rose-scented rootstock, helped early botanists recognise it as distinct from the ordinary sedums it superficially resembles. For most of its long human story, though, the plant was not cultivated at all: it was simply dug from the wild where it grew, which is exactly why its earliest records come from the people who lived in the mountains and on the northern coasts where roseroot is native.

Back to Table of Contents

The Earliest Written Record: Dioscorides

The documented medicinal history of roseroot reaches back at least to the first century of the common era. The earliest surviving written reference is traditionally credited to Pedanius Dioscorides, the Greek-born physician who served with the Roman army and whose great pharmacological work, De Materia Medica (about 77 CE), catalogued hundreds of medicinal plants and remained the central reference for Western and Islamic pharmacy for more than fifteen centuries. In it he described a plant he called rodia riza — literally “rose root” — a name that survives, in translated form, in the herb’s common names today.

It is worth being careful here, because old plant names do not always map cleanly onto modern species. What Dioscorides meant by rodia riza is generally identified with Rhodiola rosea, and the herb’s modern scientific reviews routinely cite this first-century mention as the start of its recorded use. The plant Dioscorides described was used, in the manner of the classical materia medica, as a topical and internal remedy — later European writers drawing on the same tradition applied roseroot preparations to headaches and to the skin. De Materia Medica is named here as a historical primary source rather than as a modern citation.

The significance of this early record is mostly that it exists at all. It tells us that roseroot was known, gathered, and thought worth writing down in the classical Mediterranean world — and that the “rose root” idea has been attached to the plant continuously, in one language after another, for nearly two thousand years. From that classical headwater the herb’s story splits into the separate streams of European, Siberian, and Asian folk medicine, each of which kept using it long after the ancient texts themselves were half-forgotten.

Back to Table of Contents

Linnaeus and Early European Pharmacy

The plant’s modern scientific name comes from the great Swedish naturalist Carl Linnaeus, who formally published the binomial Rhodiola rosea in his landmark Species Plantarum of 1753 — the work conventionally taken as the starting point of modern botanical naming. (Some popular accounts give an earlier date of 1725; that is not supported by the botanical record, and the 1753 publication is the authoritative one. The plant was for a long time also classified within the genus Sedum, appearing in older texts as Sedum rosea or Sedum roseum.) Linnaeus chose the names to capture the rose-like scent of the cut rootstock.

Linnaeus was not only naming the plant; he was a practising physician who recorded how it was used. In his own medical writings of the mid-eighteenth century he noted roseroot as an astringent and recommended the root for headache, for “hysteria” (a broad and now-outdated category of the day), for hernia, and for discharges (leucorrhoea). These indications reflect the medical thinking of the eighteenth century rather than any modern claim, but they show that roseroot was a recognised remedy in the European pharmacy of Linnaeus’s time.

That recognition was formalised soon after. Rhodiola rosea was included in the first Swedish Pharmacopoeia in 1755, marking its passage from folk remedy to an officially listed medicine in Sweden. Across the wider Scandinavian and northern-European folk tradition the root and its preparations were also put to humbler everyday uses — recorded uses include flavouring beer and treating the hair and scalp — the kind of practical, low-cost applications typical of a plant that grew freely on local cliffs and mountainsides and cost nothing to gather.

Back to Table of Contents

Siberian and Russian Folk Medicine

Nowhere is roseroot’s folk tradition richer or better documented than in Siberia and the Russian north, where it has been valued for centuries as zolotoy koren, the golden root. In a region defined by long, brutal winters and short growing seasons, a tough mountain plant believed to lend strength and endurance against cold and exhaustion was understandably prized, and Siberian communities built a body of customary use around it that long predates any laboratory study.

One of the most charming and frequently recorded Siberian customs concerns marriage and fertility: bouquets or pieces of the golden root were traditionally given to couples before or at marriage in the hope of promoting fertility and the birth of healthy children. Roseroot tea was also drunk as a general tonic and was widely believed to promote long life — a reputation for longevity that recurs across the herb’s folk record. In neighbouring Mongolia, traditional practitioners are recorded as having used Rhodiola for serious illnesses including tuberculosis and cancer; these are historical accounts of past practice, not endorsements of the herb as a treatment for such diseases today.

A practical thread runs alongside the folklore. In the far north, fresh plant foods were scarce through the winter, and roseroot — gathered and stored — was among the local plants that helped communities through the cold months. The Russian and Siberian folk tradition is important historically because it is the same tradition that later Soviet scientists set out to investigate: when researchers in the twentieth century went looking for a plant to study, they were not starting from nothing but following a reputation that Siberian villagers had maintained for generations.

Back to Table of Contents

Scandinavia and the Viking Tradition

Roseroot grows abundantly along the cold coasts and mountains of Scandinavia, Iceland, and the North Atlantic islands, and it has a long folk history there. The single most repeated claim about the herb — encountered on almost every product label and popular write-up — is that the Vikings used roseroot to boost their physical strength, stamina, and endurance on their long voyages and raids. It is a memorable story, and it fits both the plant’s northern range and its later reputation as a stamina herb.

Honesty requires a clear caveat. The Viking claim is best treated as tradition rather than firmly documented history. It is repeated consistently across popular and even some scientific summaries, but careful historical and scientific accounts tend either to omit it or to phrase it cautiously as something the Norse are “said to” have done; the more conservative reviews speak only of centuries of use “in Scandinavia and Russia” without naming the Vikings specifically. We include the story because it is part of the herb’s cultural identity, but readers should understand it as folklore that may well reflect genuine Norse-era use without being proven by surviving records.

What is on firmer ground is the broader Scandinavian record. Roseroot was a recognised part of northern folk medicine, was prescribed by Linnaeus and listed in the first Swedish Pharmacopoeia in 1755 (see above), and was used across Scandinavia, Iceland, and parts of the British Isles — particularly the cold, exposed regions where the plant naturally grows. The enduring northern reputation of roseroot as a herb for strength and resilience in a harsh climate is real and well attested, even where the specific Viking attribution is not.

Back to Table of Contents

Traditional Chinese and Tibetan Medicine

Roseroot and its close relatives in the genus Rhodiola — which contains scores of species across the cold mountains of Asia — also have a long place in the traditional medicine of China and Tibet, where the herb is known in Chinese as hong jing tian. In these systems Rhodiola has traditionally been used as a tonic to support energy and stamina, to invigorate the circulation, and especially to help the body cope with the thin air of high altitude.

The high-altitude use is the most distinctive strand of the Asian tradition. Because several Rhodiola species grow naturally at great elevations — thriving where oxygen is scarce — physicians in Tibet and the Himalayan regions traditionally reached for Rhodiola preparations to ease the breathlessness, fatigue, and weakness of altitude sickness and to support people living and working in the mountains. Rhodiola remains an ingredient in the traditional Tibetan and Chinese herbal repertoire today. It is worth noting that Chinese and Tibetan practice often draws on Rhodiola species other than R. rosea itself, so the Asian tradition is best understood as a tradition of the genus rather than of a single species.

A frequently retold detail links the Asian and Siberian traditions: it is said that Chinese emperors sent expeditions into Siberia in search of the prized golden root for the imperial physicians. Like the Viking story, this is a colourful and widely repeated tradition rather than a precisely documented event, and it is offered here in that spirit. What is clear is that across a vast stretch of Asia, from Tibet to the Russian Far East, Rhodiola was valued enough to be sought out, traded, and woven into more than one major system of traditional medicine.

Back to Table of Contents

The Soviet Adaptogen Program

The modern story of Rhodiola rosea begins in the Soviet Union. In the mid-twentieth century Soviet science took a deliberate, systematic interest in plants that might improve human resilience, and roseroot — with its centuries-old Siberian reputation — became one of the most studied of them. The guiding idea was the adaptogen, a term coined in 1947 by the Soviet pharmacologist Nikolai Lazarev and developed further by his colleague Israel Brekhman: a substance that helps the body resist a wide range of stresses — physical, chemical, and biological — while nudging it back toward normal balance rather than simply stimulating or sedating it.

Soviet investigation of Rhodiola was both extensive and, in its day, largely hidden. A great deal of the research was tied to the Cold War effort to improve the performance of the people the state cared most about: soldiers, cosmonauts, and Olympic athletes. Much of this adaptogen work was treated as a state secret, and the bulk of the resulting literature — by some accounts several hundred reports — was published only in Russian-language journals and remained difficult for the outside world to read for decades. This combination of genuine, sustained study and limited access is the single biggest reason roseroot was so well known in the East and so little known in the West until relatively recently.

The Soviet authorities also took the herb seriously as medicine, not merely as a research curiosity. The Soviet Ministry of Health officially registered Rhodiola rosea as a medicine in 1969, allowing it to be prescribed like a conventional drug, and in 1975 approved the large-scale production of a standardised liquid extract. By the time roseroot drew serious Western attention, it therefore arrived not as an untested folk remedy but as a herb with an established place in Soviet clinical and pharmaceutical practice — an unusual head start that shaped how it would later be studied and marketed elsewhere.

Back to Table of Contents

From Folk Tonic to Modern Recognition

As Soviet-era findings gradually became accessible and were taken up by researchers in Scandinavia, the United States, and elsewhere, attention turned to the chemistry behind the reputation. Analysts have now identified roughly 140 compounds in roseroot, and two groups stand out. The first is the rosavins — rosavin, rosarin, and rosin — which are regarded as the signature, essentially unique markers of Rhodiola rosea: they are absent or barely present in other Rhodiola species. The second is salidroside (also called rhodioloside) together with its building block tyrosol; unlike the rosavins, salidroside is shared across several Rhodiola species. High-quality roseroot extracts are commonly standardised to about a 3:1 ratio of rosavins to salidroside, a benchmark that grew directly out of this analytical work.

This chemistry matters historically because it turned a folk reputation into something testable. The unique rosavins gave manufacturers and regulators a way to confirm that a product really is R. rosea rather than a cheaper relative, and they gave scientists defined compounds to study. Over the past few decades a substantial body of clinical research — much of it focused on fatigue, stress, mood, and mental and physical performance — has grown up around standardised extracts, building on, and in places testing, the traditional claims. As with most herbs, the results are encouraging in places and mixed in others, and the honest modern position is that roseroot is a promising, generally well-tolerated supportive herb rather than a proven cure for any condition.

The clearest mark of roseroot’s passage from folk tonic to recognised medicine in the West came with the official herbal monograph of the European Medicines Agency, prepared through its Committee on Herbal Medicinal Products. The document carries the reference EMA/HMPC/232091/2011 and was formally adopted in 2012 (after a public consultation in 2011). On the basis of its long-standing use, it recognises Rhodiola rosea as a traditional herbal medicinal product for the temporary relief of symptoms of stress, such as fatigue and a sensation of weakness. (Notably, the monograph’s official indication is framed purely in terms of traditional use and these stress symptoms; it does not itself use the word “adaptogen,” even though that is how the herb is widely described elsewhere.) That careful, tradition-based wording is a fair summary of the whole journey told on this page: a tough golden root, gathered for two thousand years across the cold edges of Europe and Asia, studied intensively in secret, and now meeting modern science on its own terms. The chemistry, dosing, and clinical evidence are taken up in detail in the companion Rhodiola Rosea Benefits articles and on the main Rhodiola Rosea page.

Back to Table of Contents

Research Papers and References

The list below combines peer-reviewed reviews and clinical studies of Rhodiola rosea — chosen because they discuss its traditional and official use as well as its pharmacology — with curated PubMed topic-search links into the ethnobotanical and historical literature. Historical primary texts (Dioscorides’ De Materia Medica, Linnaeus’s eighteenth-century medical writings, and the first Swedish Pharmacopoeia) are named in the article as historical sources rather than as modern citations. Author names, titles, and journals are given as plain text; only stable DOI, PMID, and resource links are hyperlinked, and each opens in a new tab.

  1. Panossian A, Wikman G, Sarris J. Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010;17(7):481-493. — doi:10.1016/j.phymed.2010.02.002 · PMID 20378318
  2. Brown RP, Gerbarg PL, Ramazanov Z. Rhodiola rosea: A Phytomedicinal Overview. HerbalGram (American Botanical Council). 2002;56:40-52. — HerbalGram issue 56
  3. Wang S, Feng Y, Zheng L, He P, Tan J, Cai J, Wu M, Ye X. Rosavin: Research advances in extraction and synthesis, pharmacological activities and therapeutic effects on diseases of the characteristic active ingredients of Rhodiola rosea L. Molecules. 2023;28(21):7412. — doi:10.3390/molecules28217412 · PMID 37959831
  4. Olsson EM, von Schéele B, Panossian AG. A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract SHR-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica. 2009;75(2):105-112. — doi:10.1055/s-0028-1088346
  5. Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD. Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine. 2015;22(3):394-399. — doi:10.1016/j.phymed.2015.01.010 · PMID 25837277
  6. European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Community herbal monograph on Rhodiola rosea L., rhizoma et radix (ref. EMA/HMPC/232091/2011; adopted 27 March 2012; later revised). — EMA — Rhodiolae roseae rhizoma et radix
  7. Rhodiola rosea traditional use and ethnobotany — PubMed: Rhodiola rosea traditional use and ethnobotany
  8. Rhodiola rosea as an adaptogen — history and pharmacology — PubMed: Rhodiola rosea adaptogen history and pharmacology

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents